Literature DB >> 19777619

Effect of preoperative transcatheter arterial chemoembolization on angiogenesis of hepatocellular carcinoma cells.

En-Hua Xiao1, Dong Guo, Du-Jun Bian.   

Abstract

AIM: To evaluate the effects of four types of preoperative transcatheter arterial chemoembolization (TACE) on angiogenesis of hepatocellular carcinoma (HCC) cells.
METHODS: A total of 136 patients with HCC underwent liver resection. One to five courses of TACE prior to liver resection were performed in 79 patients (TACE group), in which one to four courses of chemotherapy alone were performed in 11 patients (group A); one to five courses of chemotherapy combined with iodized oil were performed in 33 patients (group B); one to three courses of chemotherapy combined with iodized oil and gelatin sponge were performed in 23 patients (group C); one to three courses of chemotherapy combined with iodized oil, ethanol and gelatin sponge were performed in 12 patients (group D). The other 57 patients only received liver resection (non-TACE group). The microvessels were marked by CD31. The expression of CD31 and vascular endothelial growth factor (VEGF) protein were detected by immunohistochemical methods.
RESULTS: The mean microvessel density (MVD) in HCC cells was significantly higher in groups A, B, C and D than in the non-TACE group (P < 0.05). The expression of VEGF protein in HCC cells were significantly higher in groups A, B, C and D than in the non-TACE group (P < 0.05). MVD and the expression of VEGF protein were positively correlated. Mean MVD and the expression of VEGF protein were closely related to the number of courses of TACE and the interval of TACE.
CONCLUSION: Four different types of preoperative TACE regimens enhanced angiogenesis in HCC cells by up-regulating the expression of VEGF protein. It is necessary to repress angiogenesis of liver cancer after TACE.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19777619      PMCID: PMC2752005          DOI: 10.3748/wjg.15.4582

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  22 in total

1.  Prognosis of primary liver carcinoma treated with local resection.

Authors:  Jianqiang Cai; Jingqun Hu; Xu Che; Jianjun Zhao; Xinyu Bi; Yongfu Shao
Journal:  Chin Med J (Engl)       Date:  2003-02       Impact factor: 2.628

2.  Effect of preoperative transcatheter arterial chemoembolization on apoptosis of hepatocellular carcinoma cells.

Authors:  Enhua Xiao; Detai Li; Shubin Shen; Shunke Zhou; Lihua Tan; Yunhua Wang; Jianguang Luo; Yuzhi Wu; Changlian Tan; Hui Liu; Hui Zhu
Journal:  Chin Med J (Engl)       Date:  2003-02       Impact factor: 2.628

3.  Transcatheter arterial chemoembolization therapy using iodized oil for patients with unresectable hepatocellular carcinoma: evaluation of three kinds of regimens and analysis of prognostic factors.

Authors:  K Ueno; N Miyazono; H Inoue; H Nishida; I Kanetsuki; M Nakajo
Journal:  Cancer       Date:  2000-04-01       Impact factor: 6.860

4.  Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma.

Authors:  Chung-Mau Lo; Henry Ngan; Wai-Kuen Tso; Chi-Leung Liu; Chi-Ming Lam; Ronnie Tung-Ping Poon; Sheung-Tat Fan; John Wong
Journal:  Hepatology       Date:  2002-05       Impact factor: 17.425

5.  Increased expression of vascular endothelial growth factor and angiogenesis in the early stage of multistep hepatocarcinogenesis.

Authors:  Y N Park; Y B Kim; K M Yang; C Park
Journal:  Arch Pathol Lab Med       Date:  2000-07       Impact factor: 5.534

6.  Transient increased expression of VEGF and MMP-1 in a rat liver tumor model after hepatic arterial occlusion.

Authors:  Wei-Jian Guo; Jie Li; Zhen Chen; Jun-Yan Zhuang; Wen-Hua Gu; Li Zhang; Jiong Pang; Chang-Hong Lu; Wen Zhu Zhang; Yu Fan Cheng
Journal:  Hepatogastroenterology       Date:  2004 Mar-Apr

7.  Association between vascular endothelial growth factor and metastasis after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma.

Authors:  Zheng-Ping Xiong; Shu-Ren Yang; Zhao-Yu Liang; En-Hua Xiao; Xiao-Ping Yu; Shen-Ke Zhou; Zi-Shu Zhang
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2004-08

Review 8.  Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials.

Authors:  Calogero Cammà; Filippo Schepis; Ambrogio Orlando; Maddalena Albanese; Lillian Shahied; Franco Trevisani; Pietro Andreone; Antonio Craxì; Mario Cottone
Journal:  Radiology       Date:  2002-07       Impact factor: 11.105

Review 9.  Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival.

Authors:  Josep M Llovet; Jordi Bruix
Journal:  Hepatology       Date:  2003-02       Impact factor: 17.425

10.  [Intratumoral microvessel density and expression of vascular endothelial growth factor in hepatocellular carcinoma after chemoembolization].

Authors:  Guoliang Shao; Jianhua Wang; Kangrong Zhou; Zhiping Yan
Journal:  Zhonghua Gan Zang Bing Za Zhi       Date:  2002-06
View more
  18 in total

Review 1.  Current status of hepatocellular carcinoma treatment in Japan: transarterial chemoembolization.

Authors:  Osamu Matsui
Journal:  Clin Drug Investig       Date:  2012-08-08       Impact factor: 2.859

2.  The Negative Effect of Preoperative Transcatheter Arterial Chemoembolization on Long-Term Outcomes for Resectable Hepatocellular Carcinoma: A Propensity Score Matching Analysis.

Authors:  Masataka Amisaki; Soichiro Honjo; Masaki Morimoto; Takehiko Hanaki; Yosuke Arai; Naruo Tokuyasu; Teruhisa Sakamoto; Yasufumi Ohuchi; Hiroaki Saito
Journal:  Yonago Acta Med       Date:  2016-12-26       Impact factor: 1.641

Review 3.  Transarterial (chemo)embolization for curative resection of hepatocellular carcinoma: a systematic review and meta-analyses.

Authors:  Xiang Cheng; Ping Sun; Qing-Gang Hu; Zi-Fang Song; Jun Xiong; Qi-Chang Zheng
Journal:  J Cancer Res Clin Oncol       Date:  2014-04-22       Impact factor: 4.553

Review 4.  Systemic Therapy for Advanced Hepatocellular Carcinoma: An Update of a Rapidly Evolving Field.

Authors:  Iliana Doycheva; Paul J Thuluvath
Journal:  J Clin Exp Hepatol       Date:  2019-08-02

Review 5.  Interventional Oncology in Hepatocellular Carcinoma: Progress Through Innovation.

Authors:  Lin Mu; Julius Chapiro; Jeremiah Stringam; Jean-François Geschwind
Journal:  Cancer J       Date:  2016 Nov/Dec       Impact factor: 3.360

6.  Comparison of the efficacy of pre-surgery and post-surgery radiotherapy in the treatment of hepatocellular carcinoma: a population-based study.

Authors:  Lei Chen; Xiaopeng Guo; Shi Chen; Yanqiao Ren; Tao Sun; Fan Yang; Chuansheng Zheng
Journal:  Am J Transl Res       Date:  2021-01-15       Impact factor: 4.060

7.  Transarterial embolization ablation of hepatocellular carcinoma with a lipiodol-ethanol mixture.

Authors:  Yang-Kui Gu; Rong-Guang Luo; Jin-Hua Huang; Qi-Jiao Si Tu; Xiao-Xia Li; Fei Gao
Journal:  World J Gastroenterol       Date:  2010-12-07       Impact factor: 5.742

8.  Anti-angiogenesis in hepatocellular carcinoma treatment: current evidence and future perspectives.

Authors:  Martin-Walter Welker; Joerg Trojan
Journal:  World J Gastroenterol       Date:  2011-07-14       Impact factor: 5.742

9.  Hepatocellular carcinoma cells surviving doxorubicin treatment exhibit increased migratory potential and resistance to doxorubicin re-treatment in vitro.

Authors:  Sebastian Buschauer; Andreas Koch; Philipp Wiggermann; Martina Müller; Claus Hellerbrand
Journal:  Oncol Lett       Date:  2018-01-26       Impact factor: 2.967

10.  Endothelial precursor cells promote angiogenesis in hepatocellular carcinoma.

Authors:  Xi-Tai Sun; Xian-Wen Yuan; Hai-Tao Zhu; Zheng-Ming Deng; De-Cai Yu; Xiang Zhou; Yi-Tao Ding
Journal:  World J Gastroenterol       Date:  2012-09-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.